SEC Form 4 · accession 0001171843-17-003274
Anika Therapeutics, Inc. · ANIK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeffery S Thompson
Director
Period of report
May 19, 2017
Accepted (ET)
May 23, 2017 · 4:56 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000898437
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 19, 2017 | S | 1,097 | $47.58 | D | 15,845 | D | |
| Common StockF2 | May 22, 2017 | S | 9,628 | $47.37 | D | 6,217 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents the weighted average sales price. The shares were sold on 5/19/2017 at prices ranging from $47.56 to $47.61 per share. Full information regarding the number of shares sold at each price shall be provided to the Staff, Issuer or any security holder, upon request.
- F2Represents the weighted average sales price. The shares were sold on 5/22/2017 at prices ranging from $47.25 to $47.45 per share. Full information regarding the number of shares sold at each price shall be provided to the Staff, Issuer or any security holder, upon request.